Has Pritesh Topiwala, MD received payments from drug or device companies?

Yes. Drug and device makers reported $30,031 in general payments to Pritesh Topiwala, MD across 236 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pritesh Topiwala, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pritesh Topiwala, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pritesh Topiwala, MD

Anesthesiology · Boston, MANPI 1386057214

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $9,798 and has fallen 70.0% since, to $2,937 in 2025. Among anesthesiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,031in general payments, 2019–2025

Across 236 payments — averaging $127.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$22K
Boston Scientific$4K
MML US, Inc.$2K
Abbott$1K
Saluda Medical Americas, Inc.$378
Vertos Medical, Inc.$356
plus $554 from 4 others

What the payments were for

Speaking & faculty fees$13,23044%
Travel & lodging$6,45922%
Food & beverage$9,86033%
Education$4832%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	141	$21,878
Boston Scientific	47	$3,574
MML US, Inc.	21	$2,138
Abbott	11	$1,152
Saluda Medical Americas, Inc.	2	$378
Vertos Medical, Inc.	3	$356
Nevro Corp.	6	$315
SPR Therapeutics, Inc	2	$175
Relievant Medsystems, Inc.	2	$49
Stimwave Technologies Incorporated	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTELLIS ADAPTIVESTIM$13,794
ReActiv8$1,943
SYNCHROMEDII$1,576
Vanta$1,351
WAVEWRITER ALPHA$1,316
RESTORE$964
SYNCHROMED$862
WaveWriter Alpha Prime 16$749
Axium INS DRG IPG$624
INTELLIS$427
Evoke SCS$339
mild Device Kit$308
GENERAL - THERAPIES$275
GENERAL PAIN MANAGEMENT$265
Senza Spinal Cord Stimulation System$192
KYPHON Balloon Kyphoplasty$174
Proclaim Family of SCS IPGs$165
SPRINT PNS System$147
Octrode SCS Leads$126
SUPERION$119

How this compares

$30,031 in reported general payments places this provider in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.

See all anesthesiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$81,376

Medicare patients

297

Services billed

786

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	30	$4,452
Pregabalin	57	$2,441
Gabapentin	106	$1,217
Tizanidine Hcl	61	$1,093
Oxycodone Hcl	62	$880
Duloxetine Hcl	13	$338
Diclofenac Sodium	31	$335
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$252
Baclofen	12	$213
Hydromorphone Hcl	13	$152
Tramadol Hcl	32	$123
Methylprednisolone	12	$100
Meloxicam	30	$85
Cyclobenzaprine Hcl	15	$80
Diazepam	22	$48

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Boston

Douglas ShookBoston$267K
Robert YongBoston$231K
Michael DambraBoston$194K
Robert TruogBoston$172K
Mary Ellen McCannBoston$140K
Stanton ShernanBoston$136K
Edgar RossBoston$129K
Sadeq QuraishiBoston$107K
James PhilipBoston$56K
Feroze Ud Din MahmoodBoston$51K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →